Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression

scientific article published on 20 November 2014

Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBI.2014.11.005
P698PubMed publication ID25452150
P5875ResearchGate publication ID268691052

P50authorJane Pei-Chen ChangQ41900767
Kuan-Pin SuQ56509488
P2093author name stringShih-Sheng Chang
Hui-Ting Yang
Mahalakshmi Palani
Chun-Ping Chen
P407language of work or nameEnglishQ1860
P921main subjectcardiovascular diseaseQ389735
P304page(s)28-31
P577publication date2014-11-20
P1433published inBrain, Behavior, and ImmunityQ15716593
P1476titlePolyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression
P478volume44

Reverse relations

cites work (P2860)
Q38901511Does Diet Matter? The Use of Polyunsaturated Fatty Acids (PUFAs) and Other Dietary Supplements in Inflammation-Associated Depression
Q35659254Fish consumption and resilience to depression in Japanese company workers: a cross-sectional study.
Q39457006Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies
Q40855688Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection

Search more.